PMID: 16507395Mar 2, 2006Paper

Cyclooxygenase-2 inhibitors suppress angiogenesis and growth of gastric cancer xenografts

Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
Y-L WuY Chen

Abstract

Many researches have confirmed the tumor-prophylactic effects of cyclooxygenase-2 (COX-2) inhibitors. We previously observed their anti-cancer effects in vivo in nude mice and found that sulindac, a traditional non-steroidal anti-inflammatory drug (NSAID), and celecoxib, a selective COX-2 inhibitor, depressed the growth of SGC7901 xenografts via altering cell kinetics. Then we deeply studied the relationship between the two drugs and angiogenesis in gastric cancer. The results showed both sulindac and celecoxib decreased the micro-vessel density (MVD), which was labeled by either CD34 or VWF staining, within xenografts. Expression of both vascular endothelial growth factor (VEGF) and FGF-1 was suppressed. In addition, a positive correlation between MVD and the volume of SGC7901 xenografts was found. The effect of selective COX-2 inhibitor was stronger than non-special one despite of the insignificant difference. These results demonstrate that COX-2 plays an important role in angiogenesis of cancer. Apart from interfering cell kinetics, decreasing the expression of angiogenic factors and then inhibiting tumor angiogenesis could also be one of the mechanisms that COX-2 inhibitors suppress the growth of gastric cancer. These findi...Continue Reading

References

Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·W L XieD L Simmons
Sep 1, 1983·Journal of Surgical Oncology·W R Waddell, R W Loughry

❮ Previous
Next ❯

Citations

Nov 5, 2010·Journal of Translational Medicine·Wings T Y LooLouis W C Chow
Feb 3, 2007·American Journal of Veterinary Research·Carey L McInnisJames R Turk
Apr 17, 2009·Current Oncology·O G ScharovskyV R Rozados
Jun 13, 2009·World Journal of Gastroenterology : WJG·Li-Jing ZhangJun Yu
Dec 21, 2007·Digestive Diseases and Sciences·Yan-Shi GuoMark R Hellmich
Jan 23, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiaochun ShenQiaoming Zhi
Apr 3, 2007·Neoplasia : an International Journal for Oncology Research·Mark A ScheperJohn J Sauk
Apr 28, 2007·European Journal of Pharmacology·Hossam M M ArafaFarid M A Hamada
Jul 3, 2008·International Wound Journal·Andrej RingStefan Langer
Sep 5, 2007·Alimentary Pharmacology & Therapeutics·A LanasJ M Pique
Jun 9, 2009·Acta Cirúrgica Brasileira·Frederico Theobaldo Ramos RochaAntenor Teixeira Leal
Apr 24, 2007·International Journal of Cancer. Journal International Du Cancer·Takanobu IrieNorio Hayashi
Apr 3, 2007·Nature Medicine·Praveen BallabhMaiken Nedergaard
Sep 5, 2019·International Journal of Molecular Sciences·Shanzana KhanJaye P F Chin-Dusting
May 29, 2008·Angiology·Mehmet SahinSaadet Gümüslü
Feb 5, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Lei DuanLeslie Bernstein
Nov 19, 2020·Clinical Journal of Gastroenterology·Alicja FormaMonika Sitarz
Jul 27, 2021·Frontiers in Immunology·Esha SehanobishElina Jerschow

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Related Papers

Digestive Diseases and Sciences
Soo-Jeong ChoIn Sung Song
The Journal of Clinical Investigation
B Tycko
Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie
L W C ChowE L H Lui
© 2021 Meta ULC. All rights reserved